U S Diagnostics Inc New York City, NY - 10010

U S Diagnostics Inc is categorized under Diagnostic Substances in New York City, NY and active since 2005.

U S Diagnostics Inc was established in 2005, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.

If you are seeking more information, feel free to contact Edward Letko at the company’s single location by writing to 304 Park Avenue South # 218, New York City, New York NY 10010 or by phoning (866) 216-5308. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: U S Diagnostics Inc
Contact Person: Edward Letko
Address: 304 Park Avenue South # 218, New York City, New York 10010
Phone Number: (866) 216-5308
Website Address: usdiagnostics.net
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Diagnostic Substances
SIC Code: 2835
NAICS Code: 325412
Share This Business:

U S Diagnostics Inc was started in 2005 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Edward Letko for inquiries that concern U S Diagnostics Inc by calling the company number (866) 216-5308, as your correspondence is most welcome. Additionally, the physical location of the single location of U S Diagnostics Inc can be found at the coordinates 40.740158,-73.986666 as well as the street address 304 Park Avenue South # 218 in New York City, New York 10010.

For its online presence, you may visit U S Diagnostics Inc’s website at usdiagnostics.net and engage with its social media outlets through on Twitter and on Facebook.